Saliva/Pathogen Biomarker Signatures and Periodontal Disease Progression

The purpose of this study was to determine the role of saliva-derived biomarkers and periodontal pathogens during periodontal disease progression (PDP). One hundred human participants were recruited into a 12-month investigation. They were seen bi-monthly for saliva and clinical measures and bi-annu...

Full description

Saved in:
Bibliographic Details
Published inJournal of dental research Vol. 90; no. 6; pp. 752 - 758
Main Authors Kinney, J.S., Morelli, T., Braun, T., Ramseier, C.A., Herr, A.E., Sugai, J.V., Shelburne, C.E., Rayburn, L.A., Singh, A.K., Giannobile, W.V.
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.06.2011
International Association for Dental Research
SAGE PUBLICATIONS, INC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study was to determine the role of saliva-derived biomarkers and periodontal pathogens during periodontal disease progression (PDP). One hundred human participants were recruited into a 12-month investigation. They were seen bi-monthly for saliva and clinical measures and bi-annually for subtraction radiography, serum and plaque biofilm assessments. Saliva and serum were analyzed with protein arrays for 14 pro-inflammatory and bone turnover markers, while qPCR was used for detection of biofilm. A hierarchical clustering algorithm was used to group study participants based on clinical, microbiological, salivary/serum biomarkers, and PDP. Eighty-three individuals completed the six-month monitoring phase, with 44 exhibiting PDP, while 39 demonstrated stability. Participants assembled into three clusters based on periodontal pathogens, serum and salivary biomarkers. Cluster 1 members displayed high salivary biomarkers and biofilm; 82% of these individuals were undergoing PDP. Cluster 2 members displayed low biofilm and biomarker levels; 78% of these individuals were stable. Cluster 3 members were not discriminated by PDP status; however, cluster stratification followed groups 1 and 2 based on thresholds of salivary biomarkers and biofilm pathogens. The association of cluster membership to PDP was highly significant (p < 0.0002). The use of salivary and biofilm biomarkers offers potential for the identification of PDP or stability (ClinicalTrials.gov number, CT00277745).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0022-0345
1544-0591
1544-0591
DOI:10.1177/0022034511399908